Bacterial isolates obtained in Israel from stool cultures of 17 sporadic cases of acute diarrhea during the years 1972 to 1980 and from 14 patients involved in an institutional outbreak in 1984 are described. These cultures gave the biochemical reactions and pathogenicity tests characteristics of the genus Shigella but failed to agglutinate, living or boiled, in any of the recognized or provisional Shigella antisera. All 31 cultures were biochemically and serologically identical, and owing to their inability to ferment mannitol, it is proposed that they be regarded as belonging to a new provisional serovar of Shigella dysenteriae. The strain I9809-73 is designated as the test strain for this new serovar.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC271621PMC
http://dx.doi.org/10.1128/jcm.21.2.240-242.1985DOI Listing

Publication Analysis

Top Keywords

provisional serovar
8
serovar shigella
8
shigella dysenteriae
8
shigella
4
dysenteriae bacterial
4
bacterial isolates
4
isolates israel
4
israel stool
4
stool cultures
4
cultures sporadic
4

Similar Publications

Previous studies demonstrated that , a saprophytic species, triggers innate immune responses in the host during early infection. This raised the question of whether these responses could suppress a subsequent challenge with pathogenic . We inoculated C3H/HeJ mice with a single or a double dose of before challenge with a pathogenic serovar, serovar Copenhageni FioCruz (LIC).

View Article and Find Full Text PDF
Article Synopsis
  • A bacterial pathogen causes serious infections, especially hemorrhagic septicemia in cattle and buffaloes, leading to high mortality and significant socio-economic challenges for smallholder farmers in Africa and Asia.
  • Researchers have identified a novel vaccine target, PmSLP-3, which has shown strong protective effects in cattle against serogroup B strains.
  • PmSLP-3, combined with Montanide ISA 61, effectively produces long-lasting immunity in cattle, demonstrating protection against both serogroup B and E challenges, with sustained antibody levels found for up to three years after vaccination.
View Article and Find Full Text PDF

Development of a sequence-based OspA typing method for .

Microb Genom

May 2024

Vaccine Research and Development, Pfizer, Inc., Pearl River, NY, 10965, USA.

Lyme disease (LD), caused by spirochete bacteria of the genus , remains the most common vector-borne disease in the northern hemisphere. outer surface protein A (OspA) is an integral surface protein expressed during the tick cycle, and a validated vaccine target. There are at least 20 recognized genospecies, that vary in OspA serotype.

View Article and Find Full Text PDF

The present study included three Aeromonas sp. strains isolated from fish tissues during Motile Aeromonas Infection/Motile Aeromonas Septicaemia disease outbreaks on commercial farms, i.e.

View Article and Find Full Text PDF

Aeromonas sobria strain K928 was isolated from a common carp during a Motile Aeromonas Infection/Motile Aeromonas Septicaemia disease outbreak on a Polish fish farm and classified into the new provisional PGO1 serogroup. The lipopolysaccharide of A. sobria K928 was subjected to mild acid hydrolysis, and the O-specific polysaccharide, which was isolated by gel-permeation chromatography, was studied using sugar and methylation analyses and H and C NMR spectroscopy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!